Effectiveness of recombinant human bone morphogenetic protein-7 in the management of congenital pseudoarthrosis of the tibia: a randomised controlled trial
- 15 May 2014
- journal article
- research article
- Published by Springer Nature in International Orthopaedics
- Vol. 38 (9) , 1987-1992
Abstract
Despite the popularity and an increased use of bone morphogenetic protein to improve bone healing in patients with congenital pseudoarthrosis of the tibia (CPT), no previous study has compared its efficacy against any other procedure. We randomised 20 consecutive patients (mean age 4.1 years) with CPT (Crawford type IV) associated with neurofibromatosis type 1(NF1) and no previous history of surgery into two groups. Group 1 received recombinant human bone morphogenetic protein-7 (rhBMP-7) along with intramedullary Kirschner (K)-wire fixation and autologous bone grafting; group 2 received only K wire and grafting. Outcome measures were time to achieve union, Johnston grade, tibial length and the American Orthopaedic Foot and Ankle Society (AOFAS) score, which were evaluated preoperatively and at five year follow-up. Study results showed that patients in group 1 achieved primary bone union at a mean of 14.5 months [standard error (SE) 5.2], whereas group 2 took a mean of 17.11 months (SE 5.0). However, the log-rank test showed no difference in healing times between groups at all time points (P = 0.636). There was a statistically significant pre- to post operative improvement (P < 0.05) within groups for the other outcome measures. In a five year follow-up, these results suggest that rh-BMP-7 and autologous bone grafting is no better than autologous grafting alone.Keywords
This publication has 42 references indexed in Scilit:
- Ilizarov Treatment of Congenital Pseudarthrosis of the Tibia: A Multi-Targeted Approach Using the Ilizarov TechniqueClinics in Orthopedic Surgery, 2011
- Enhancement of Difficult Nonunion in Children with Osteogenic Protein-1 (OP-1): Early ExperienceClinical Orthopaedics and Related Research, 2009
- Periosteal Grafting for Congenital Pseudarthrosis of the Tibia: A Preliminary ReportClinical Orthopaedics and Related Research, 2008
- Long-term follow-up on the use of vascularized fibular graft for the treatment of congenital pseudarthrosis of the tibiaJournal of Orthopaedic Surgery and Research, 2008
- Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal fusionInternational Orthopaedics, 2007
- Bone morphogenetic protein 7 in the treatment of congenital pseudarthrosis of the tibiaThe Journal of Bone and Joint Surgery. British volume, 2006
- Bone Morphogenetic ProteinsGrowth Factors, 2004
- Outcome of surgically treated intraarticular calcaneus fractures—SF-36 compared with AOFAS and MFSActa Orthopaedica, 2004
- Treatment Approaches for Congenital Pseudarthrosis of Tibia: Results of the EPOS Multicenter StudyJournal of Pediatric Orthopaedics B, 2000
- Clinical Rating Systems for the Ankle-Hindfoot, Midfoot, Hallux, and Lesser ToesFoot & Ankle International, 1994